Dani Qin | Cardiovascular Disease | Best Researcher Award

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award 

 Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile 

 

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.